BriaCell TherapeuticsBCTX 
$0.70-2.53%24h
-2.53%24h
Global rank32343
Market cap$10.96M
Change 7d-11.16%
YTD Performance-88.11%
SP500 benchmarkUnderperform
P/E-0.54
P/S0
Revenue$0
Earnings-$20.30M
Dividend yield-
BriaCell Therapeutics (BCTX) Total Liabilities
BCTX Total Liabilities in 2022: $41.38M
According to BriaCell Therapeutics latest financial reports the total liabilities of BCTX is $41.38M, an decrease of -4.05% to 2022. At the end of 2022 company had $43.13M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that BriaCell Therapeutics is responsible for during its operational activities.
BriaCell Therapeutics (BCTX) Total Liabilities History from 2023 to 2022
-
Value:-
BCTX Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $41.38M | -4.05% |
| 2022 | $43.13M | 6.18% |
| 2021 | $40.62M | 885.93% |
| 2020 | $4.12M | 1267.19% |
| 2019 | $301.33K | - |
View the Top Total Liabilies Stocks
